Studies be published in the Jan. 10 edition of the New England Journal of tonic (NEJM) are with the proviso clues into the treatment and conclusion of LAM, or lymphangioleiomyomatosis, a progressive and deadly lung disease that affects women in their childbearing years. There currently are no treatments for LAM and scientists estimate as many as 250,000 women may be going misdiagnosed or undiagnosed.

More: - Brought to my attention by